type-1-diabetes

Documents about type-1-diabetes

• Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol#448200ClinicalTrials.gov
• Threshold Suspend in Pediatrics at Home#148682ClinicalTrials.gov
• Primary Intervention With Mucosal Insulin#238287ClinicalTrials.gov
• MyT1DHero: an mHealth Intervention for Type 1 Diabetes#279640ClinicalTrials.gov
• Artificial Pancreas in Pediatric Patients (PEDarPAN)#405281ClinicalTrials.gov
• Qingdao: Insulin Pump Follow-Up Program#442040ClinicalTrials.gov
• Psychological Aspects and Insulin Pump Therapy#463680ClinicalTrials.gov
• Diabetes Technologies in Ultra-Endurance Type 1 Diabetes: Qualitative Study.#165866NCBI PubMed Central
• GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration#184803ClinicalTrials.gov
• Type 1 Diabetes Polygenic Scores Improve Diagnostic Accuracy in Pediatric Diabetes Care.#209464NCBI PubMed Central
• Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes#426699ClinicalTrials.gov
• Diabetes Journey: An Adolescent Adherence Barriers Intervention#474884ClinicalTrials.gov
• A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria#152595ClinicalTrials.gov
• Family Management of Childhood Diabetes Study#426734ClinicalTrials.gov
• Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India#824976ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone#18529ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#230380ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea#300424ClinicalTrials.gov
• The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes#290928ClinicalTrials.gov
• A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia#398245ClinicalTrials.gov
• A Review of Informed Consent for Porcine Islet Xenotransplantation to Treat Type 1 Diabetes.#409742PubMed
• Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset#474862ClinicalTrials.gov
• Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes#651197ClinicalTrials.gov
• The Effect of Kamishibai Diabetes Education on Knowledge, HbA1c, and Quality of Life in Children#803719ClinicalTrials.gov
• Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System#807851ClinicalTrials.gov
• Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature#391046ClinicalTrials.gov
• Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes Mellitus#803230ClinicalTrials.gov
• Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients#407843ClinicalTrials.gov
• Comparison of SmartGuard vs Temp Target in Patients With Type 1 Diabetes Users of Advanced Hybrid Closed Loop System (AHCL) in Anaerobic Physical Activity.#154845ClinicalTrials.gov
• An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus#230312ClinicalTrials.gov
• Prediction of Nocturnal Hypoglycemia Following Exercise in Type 1 Diabetes Using Temporally Structured CGM-Derived Digital Biomarkers#445516Europe PMC
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin#154863ClinicalTrials.gov
• Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes#201720ClinicalTrials.gov
• Carbohydrate Counting and Bolus Calculator Mobile Application Improves Time in Range in Adults With Type 1 Diabetes#828575ClinicalTrials.gov
• Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes#158174ClinicalTrials.gov
• GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)#18685ClinicalTrials.gov
• Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy#123622ClinicalTrials.gov
• Cardiometabolic Risk in Children With Type 1 Diabetes.#143759ClinicalTrials.gov
• Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program#160266ClinicalTrials.gov
• Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use#234571ClinicalTrials.gov
• Acceptance and Value Based Methods in Increasing Wellbeing of Adolescents With Type 1 Diabetes#272274ClinicalTrials.gov
• Current State of Impaired Awareness of Hypoglycaemia in People With Type 1 Diabetes#321631ClinicalTrials.gov
• Additional Insulin for Fat and Protein in Children With Diabetes Study#435696ClinicalTrials.gov
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy#674862ClinicalTrials.gov
• Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes#217192ClinicalTrials.gov
• In Clinic Evaluation of the PLGM Feature#329478ClinicalTrials.gov
• The Loop Observational Study#394694ClinicalTrials.gov
• GLP-1 Infusion and Long-Time Fasting#411346ClinicalTrials.gov
• To Evaluate the Bioavailability of a Tablet of AZD1656#435697ClinicalTrials.gov
• T1DM Immunotherapy Using Polyclonal Tregs + IL-2#435736ClinicalTrials.gov